Plasmapheresis does not affect polysomnographic parameters in patients with myasthenia gravis: A case series study

Jiann Horng Yeh, Wei Hung Chen, Hou Chang Chiu, Chien Te Lee, Chung Yao Hsu

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The purpose of this study was to evaluate the influence of plasmapheresis on sleep in patients with generalized myasthenia gravis and no respiratory symptoms. Seven myasthenia gravis patients, four women and three men, aged 24-52 years, underwent plasmapheresis treatment because of recent worsening of clinical weakness and poor response to previous treatments. We prospectively recorded the myasthenia gravis score, measured acetylcholine-receptor antibody concentration, performed polysomnography, and checked the Epworth Sleepiness Scale at baseline and 1 day after completion of the last session of plasmapheresis. Myasthenic weakness was ameliorated following plasmapheresis in all patients with a median decrease in myasthenia gravis score of 2 points (P = 0.0002) and a median clearance of 43.3% of acetylcholine-receptor antibody. However, there was no significant change in polysomnographic parameters, except for a trend toward shorter duration of the longest apnea period (P = 0.0763) following the treatment. Plasmapheresis did not affect polysomnographic parameters despite improved clinical weakness along with decreased myasthenia gravis score and acetylcholine-receptor antibody concentration.

Original languageEnglish
JournalArtificial Organs
Volume34
Issue number6
DOIs
Publication statusPublished - Jun 2010

Fingerprint

Plasmapheresis
Myasthenia Gravis
Cholinergic Receptors
Antibodies
Polysomnography
Muscle Weakness
Apnea
Sleep
Therapeutics

Keywords

  • Acetylcholine-receptor antibody
  • Double-filtration plasmapheresis
  • Myasthenia gravis
  • Polysomnography
  • Sleep-disordered breathing

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Bioengineering
  • Medicine (miscellaneous)
  • Medicine(all)

Cite this

Plasmapheresis does not affect polysomnographic parameters in patients with myasthenia gravis : A case series study. / Yeh, Jiann Horng; Chen, Wei Hung; Chiu, Hou Chang; Lee, Chien Te; Hsu, Chung Yao.

In: Artificial Organs, Vol. 34, No. 6, 06.2010.

Research output: Contribution to journalArticle

Yeh, Jiann Horng ; Chen, Wei Hung ; Chiu, Hou Chang ; Lee, Chien Te ; Hsu, Chung Yao. / Plasmapheresis does not affect polysomnographic parameters in patients with myasthenia gravis : A case series study. In: Artificial Organs. 2010 ; Vol. 34, No. 6.
@article{a70efbffb714431b8f0d6b679a8a1a60,
title = "Plasmapheresis does not affect polysomnographic parameters in patients with myasthenia gravis: A case series study",
abstract = "The purpose of this study was to evaluate the influence of plasmapheresis on sleep in patients with generalized myasthenia gravis and no respiratory symptoms. Seven myasthenia gravis patients, four women and three men, aged 24-52 years, underwent plasmapheresis treatment because of recent worsening of clinical weakness and poor response to previous treatments. We prospectively recorded the myasthenia gravis score, measured acetylcholine-receptor antibody concentration, performed polysomnography, and checked the Epworth Sleepiness Scale at baseline and 1 day after completion of the last session of plasmapheresis. Myasthenic weakness was ameliorated following plasmapheresis in all patients with a median decrease in myasthenia gravis score of 2 points (P = 0.0002) and a median clearance of 43.3{\%} of acetylcholine-receptor antibody. However, there was no significant change in polysomnographic parameters, except for a trend toward shorter duration of the longest apnea period (P = 0.0763) following the treatment. Plasmapheresis did not affect polysomnographic parameters despite improved clinical weakness along with decreased myasthenia gravis score and acetylcholine-receptor antibody concentration.",
keywords = "Acetylcholine-receptor antibody, Double-filtration plasmapheresis, Myasthenia gravis, Polysomnography, Sleep-disordered breathing",
author = "Yeh, {Jiann Horng} and Chen, {Wei Hung} and Chiu, {Hou Chang} and Lee, {Chien Te} and Hsu, {Chung Yao}",
year = "2010",
month = "6",
doi = "10.1111/j.1525-1594.2009.00975.x",
language = "English",
volume = "34",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Plasmapheresis does not affect polysomnographic parameters in patients with myasthenia gravis

T2 - A case series study

AU - Yeh, Jiann Horng

AU - Chen, Wei Hung

AU - Chiu, Hou Chang

AU - Lee, Chien Te

AU - Hsu, Chung Yao

PY - 2010/6

Y1 - 2010/6

N2 - The purpose of this study was to evaluate the influence of plasmapheresis on sleep in patients with generalized myasthenia gravis and no respiratory symptoms. Seven myasthenia gravis patients, four women and three men, aged 24-52 years, underwent plasmapheresis treatment because of recent worsening of clinical weakness and poor response to previous treatments. We prospectively recorded the myasthenia gravis score, measured acetylcholine-receptor antibody concentration, performed polysomnography, and checked the Epworth Sleepiness Scale at baseline and 1 day after completion of the last session of plasmapheresis. Myasthenic weakness was ameliorated following plasmapheresis in all patients with a median decrease in myasthenia gravis score of 2 points (P = 0.0002) and a median clearance of 43.3% of acetylcholine-receptor antibody. However, there was no significant change in polysomnographic parameters, except for a trend toward shorter duration of the longest apnea period (P = 0.0763) following the treatment. Plasmapheresis did not affect polysomnographic parameters despite improved clinical weakness along with decreased myasthenia gravis score and acetylcholine-receptor antibody concentration.

AB - The purpose of this study was to evaluate the influence of plasmapheresis on sleep in patients with generalized myasthenia gravis and no respiratory symptoms. Seven myasthenia gravis patients, four women and three men, aged 24-52 years, underwent plasmapheresis treatment because of recent worsening of clinical weakness and poor response to previous treatments. We prospectively recorded the myasthenia gravis score, measured acetylcholine-receptor antibody concentration, performed polysomnography, and checked the Epworth Sleepiness Scale at baseline and 1 day after completion of the last session of plasmapheresis. Myasthenic weakness was ameliorated following plasmapheresis in all patients with a median decrease in myasthenia gravis score of 2 points (P = 0.0002) and a median clearance of 43.3% of acetylcholine-receptor antibody. However, there was no significant change in polysomnographic parameters, except for a trend toward shorter duration of the longest apnea period (P = 0.0763) following the treatment. Plasmapheresis did not affect polysomnographic parameters despite improved clinical weakness along with decreased myasthenia gravis score and acetylcholine-receptor antibody concentration.

KW - Acetylcholine-receptor antibody

KW - Double-filtration plasmapheresis

KW - Myasthenia gravis

KW - Polysomnography

KW - Sleep-disordered breathing

UR - http://www.scopus.com/inward/record.url?scp=77953218593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953218593&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1594.2009.00975.x

DO - 10.1111/j.1525-1594.2009.00975.x

M3 - Article

C2 - 20456321

AN - SCOPUS:77953218593

VL - 34

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 6

ER -